Kamada to Announce Third Quarter and Nine Months Ended September 30, 2026, Financial Results on November 9, 2026GlobeNewsWire • Monday
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026GlobeNewsWire • 10/19/26
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in IsraelGlobeNewsWire • 10/06/26
CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased DemandGlobeNewsWire • 09/17/26
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire • 09/10/26
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to ShareholdersGlobeNewsWire • 09/03/26
AI Exhaustion? 3 Healthcare Stocks With 38% EPS Growth That Could Be The CureSeeking Alpha • 09/01/26
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026GlobeNewsWire • 08/17/26
Wall Street Analysts Think Kamada (KMDA) Could Surge 79.06%: Read This Before Placing a BetZacks Investment Research • 08/14/26
Kamada (KMDA) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/12/26
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual GuidanceGlobeNewsWire • 08/12/26
Curious about Kamada (KMDA) Q2 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 08/07/26
Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026GlobeNewsWire • 08/05/26
Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived TherapiesGlobeNewsWire • 07/20/26
Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual MeetingGlobeNewsWire • 07/13/26
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing LaboratoryGlobeNewsWire • 06/01/26